Chairperson. Chad Gwaltney, ERT and Annabel Nixon, PRMA Consulting Ltd
To advance the scientific development and evaluation of study endpoints and the assessments that underlie them, including:
- Patient reported outcomes (PROs)
- Clinician reported outcomes (ClinROs)
- Observer reported outcomes (ObsROs)
- Performance outcomes (PerfOs)
To facilitate discussion about study endpoints among all medical product development stakeholders;
To educate professionals in the biopharmaceutical and healthcare industries about scientific approaches to the development and evaluation of study endpoints; and
To publish best practice documents that can be used by a variety of stakeholders to develop and evaluate study endpoints.
Take advantage of all the benefits of membership.
Become a DIA Member
Instant Download! Beyond Taxonomy
This audiosynchronized presentation explores the taxonomy of study endpoints and its importance to study design.
Manage My Community Memberships